Total Payments
$144,690
2024 Payments
$3,538
Companies
43
Transactions
690
Medicare Patients
7,919
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$98,159 (67.8%)
Travel$20,658 (14.3%)
Food & Beverage$16,526 (11.4%)
Consulting$9,120 (6.3%)
Education$228.18 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $97,759 | 47 | 67.6% |
| Travel and Lodging | $20,658 | 74 | 14.3% |
| Food and Beverage | $16,526 | 557 | 11.4% |
| Consulting Fee | $9,120 | 3 | 6.3% |
| Honoraria | $400.00 | 1 | 0.3% |
| Education | $228.18 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $62,217 | 144 | $0 (2024) |
| Relypsa, Inc. | $33,580 | 70 | $0 (2020) |
| Mallinckrodt Enterprises LLC | $29,919 | 55 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $4,422 | 39 | $0 (2024) |
| Baxter Healthcare | $4,383 | 38 | $0 (2024) |
| Vifor Pharma, Inc. | $1,585 | 16 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,121 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $981.98 | 39 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $812.37 | 40 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $551.32 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,538 | 53 | Baxter Healthcare ($2,070) |
| 2023 | $2,016 | 69 | Bayer Healthcare Pharmaceuticals Inc. ($339.83) |
| 2022 | $3,662 | 84 | Vifor Pharma, Inc. ($1,346) |
| 2021 | $2,237 | 91 | AstraZeneca Pharmaceuticals LP ($299.14) |
| 2020 | $5,315 | 39 | Mallinckrodt Hospital Products Inc. ($3,436) |
| 2019 | $29,622 | 108 | Relypsa, Inc. ($17,342) |
| 2018 | $28,997 | 89 | Mallinckrodt LLC ($11,344) |
| 2017 | $69,304 | 157 | Novartis Pharmaceuticals Corporation ($52,095) |
All Payment Transactions
690 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Genetic Disease | ||||||
| 12/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: CRITICAL CARE | ||||||
| 11/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $32.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $28.76 | General |
| Category: NEPHROLOGY | ||||||
| 10/22/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $37.75 | General |
| 10/22/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Catheter Lock Solution | ||||||
| 09/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $51.99 | General |
| Category: Nephrology | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $67.77 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Genetic Disease | ||||||
| 08/20/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: Nephrology | ||||||
| 08/13/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEPHROLOGY | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: Cardio-renal | ||||||
| 07/17/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Nephrology | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.75 | General |
| 07/03/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: CRITICAL CARE | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.49 | General |
| 05/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,494 | 2,873 | $640,250 | $331,748 |
| 2022 | 13 | 1,603 | 2,506 | $586,175 | $331,059 |
| 2021 | 13 | 2,340 | 3,692 | $794,200 | $456,869 |
| 2020 | 14 | 2,482 | 4,077 | $849,260 | $431,072 |
Total Patients
7,919
Total Services
13,148
Medicare Billing
$1.6M
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 92 | 309 | $154,350 | $90,398 | 58.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 725 | 972 | $145,800 | $77,483 | 53.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 39 | 206 | $92,700 | $50,625 | 54.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 72 | 173 | $72,250 | $42,025 | 58.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $25,250 | $12,858 | 50.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 82 | $24,600 | $8,590 | 34.9% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 44 | 163 | $20,375 | $8,117 | 39.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 52 | 78 | $15,600 | $7,382 | 47.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 44 | 169 | $16,900 | $6,555 | 38.8% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 42 | 144 | $14,400 | $5,540 | 38.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 44 | 165 | $16,500 | $5,227 | 31.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 43 | 129 | $12,900 | $5,046 | 39.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 26 | $6,500 | $3,596 | 55.3% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 17 | 20 | $6,700 | $3,310 | 49.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 43 | $8,600 | $2,784 | 32.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 15 | 18 | $2,700 | $1,048 | 38.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 44 | 60 | $3,000 | $922.78 | 30.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 15 | $1,125 | $240.89 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 932 | 1,292 | $193,800 | $92,803 | 47.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 89 | 256 | $109,025 | $76,528 | 70.2% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 37 | 207 | $84,150 | $52,370 | 62.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 82 | 168 | $59,400 | $41,212 | 69.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 196 | 196 | $48,800 | $25,183 | 51.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 49 | 93 | $23,250 | $15,525 | 66.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 66 | 96 | $19,200 | $7,856 | 40.9% |
About Mark Russo, MD, PHD
Mark Russo, MD, PHD is a Nephrology healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316934326.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Russo, MD, PHD has received a total of $144,690 in payments from pharmaceutical and medical device companies, with $3,538 received in 2024. These payments were reported across 690 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($97,759).
As a Medicare-enrolled provider, Russo has provided services to 7,919 Medicare beneficiaries, totaling 13,148 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Naples, FL
- Active Since 10/04/2005
- Last Updated 09/11/2013
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1316934326
Products in Payments
- ENTRESTO (Drug) $61,723
- Veltassa (Drug) $35,165
- ACTHAR (Biological) $34,223
- Renal - PD (Device) $2,346
- Non-Franchise (NOF) - NonProduct (Biological) $1,282
- Kerendia (Drug) $1,121
- LOKELMA (Drug) $535.29
- KRYSTEXXA (Biological) $485.18
- BENLYSTA (Biological) $441.61
- Rayaldee (Drug) $435.74
- FARXIGA (Drug) $424.22
- RAYALDEE (Drug) $350.81
- SAMSCA (Drug) $325.12
- ONPATTRO (Drug) $311.45
- Renal - CRRT (Device) $294.22
- Parsabiv (Drug) $243.69
- LUPKYNIS (Drug) $240.60
- INJECTAFER (Drug) $230.92
- JYNARQUE (Drug) $226.20
- TARPEYO (Drug) $199.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Naples
Nijal Sheth
Nephrology — Payments: $35,580
Nephrology $35,580
Vera Stricevic, M.d, M.D
Nephrology — Payments: $6,112
Nephrology $6,112
Joji Urlanda, M.d, M.D
Nephrology — Payments: $2,753
Nephrology $2,753
Krystine Swannick-Konopczynski, Md, MD
Nephrology — Payments: $2,079
Nephrology $2,079
Dr. Merrit Gadallah, Md, MD
Nephrology — Payments: $2,007
Nephrology $2,007
James Sterrett, Md, MD
Nephrology — Payments: $1,225
Nephrology $1,225